Articles by Mark Mirochnick, M.D.

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Pinto, Jorge A.; Capparelli, Edmund V.; Warshaw, Meredith; More

The Pediatric Infectious Disease Journal. ., Post Acceptance: October 28, 2017

Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057

Osorio, Luiz Eduardo; Boechat, Maria Ines; Mirochnick, Mark; More

The Pediatric Infectious Disease Journal. 36(2):184-188, February 2017.

Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-infected Breastfeeding Infants

Fogel, Jessica M.; Mwatha, Anthony; Richardson, Paul; More

The Pediatric Infectious Disease Journal. 32(4):e164-e169, April 2013.

Nelfinavir and Lamivudine Pharmacokinetics During the First Two Weeks of Life

Mirochnick, Mark; Nielsen-Saines, Karin; Pilotto, Jose Henrique; More

The Pediatric Infectious Disease Journal. 30(9):769-772, September 2011.

Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus

MCINTOSH, KENNETH; COOPER, ELLEN; XU, JING; More

The Pediatric Infectious Disease Journal. 18(5):432-439, May 1999.